Related Experiment Videos
Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis
1Medical Scholars Program, Stanford University School of Medicine, San Francisco, CA.
American Journal of Public Health
|May 1, 1990
Summary
The leukocyte esterase urine dipstick test is the most cost-effective screening method for Chlamydia trachomatis in adolescent males. This screening approach offers significant cost savings compared to other methods and no screening.
Area of Science:
- Urology
- Public Health
- Infectious Diseases
Background:
- Chlamydia trachomatis infections are common in sexually active adolescent males.
- Effective screening strategies are crucial for early detection and treatment to prevent complications.
Purpose of the Study:
- To evaluate the cost-effectiveness of the leukocyte esterase urine dipstick test for Chlamydia trachomatis screening in adolescent males.
- To compare this test against other diagnostic methods and no screening.
Main Methods:
- A decision analysis model was developed to assess costs and benefits.
- The leukocyte esterase test was compared with culture, direct-smear fluorescent antibody (DFA), and no screening.
Main Results:
- The leukocyte esterase test demonstrated the lowest average cost-per-cure at $51, significantly lower than DFA ($192) and culture ($414).
- Screening 1,000 males with the leukocyte esterase test is estimated to save over $9,727 compared to DFA.
- Sensitivity analyses confirmed the leukocyte esterase test's cost-effectiveness across various infection prevalences.
Conclusions:
- The leukocyte esterase urine dipstick test is a highly cost-effective screening tool for Chlamydia trachomatis in adolescent males.
- Implementing this screening method can lead to substantial healthcare cost reductions and improved patient outcomes.